A natural antiviral and immunomodulatory compound with antiangiogenic properties

Microvascular Research

Volumn 84, Issue 3, 2012, Pages 235-241

  Bueno, Carlos A ^a   Lombardi, María G ^b   Sales, María E ^b   Alché, Laura E ^a  

^a Laboratorio de Virologia Ciudad Autonoma de Buenos Aires   (Argentina)

^b Centre de Estudios Farmacologicos y Botanicos   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

1 CINNAMOYL 3,11 DIHYDROXYMELIACARPIN; ANGIOGENESIS INHIBITOR; ANTIVIRUS AGENT; IMMUNOMODULATING AGENT; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MELIACINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL FUNCTION; CELL STIMULATION; CELL VIABILITY; CHEMOTAXIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; MIGRATION INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL VEIN ENDOTHELIAL CELL;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTIVIRAL AGENTS; CELL PROLIFERATION; CHEMISTRY, PHARMACEUTICAL; CHEMOTAXIS; DRUG DESIGN; FEMALE; GENE EXPRESSION REGULATION; HERPESVIRUS 1, HUMAN; HUMANS; IMMUNOLOGIC FACTORS; LIPOPOLYSACCHARIDES; MELIA; MICE; MICE, INBRED BALB C; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDES; PLANT EXTRACTS; PLANT PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

HUMAN HERPESVIRUS 1; MELIA AZEDARACH; MURINAE; MUS;

EID: 84868121963     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2012.09.003     Document Type: Article

References (26)

1. Albini A., Tosetti F., Benelli R., Noonan D.M. Tumor inflammatory angiogenesis and its chemoprevention. Cancer Res. 2005, 65:10637-10641.
2. Alché L.E., Assad Ferek G., Meo M., Coto C., Maier M. An antiviral meliacarpin from leaves of Melia azedarach L. Z. Naturforsch. C 2003, 58:215-219.
3. Barquero A.A., Alché L.E., Coto C. Block of vesicular stomatitis virus endocytic and exocytic pathways by 1-cinnamoyl-3,11-dihydroxymeliacarpin, a tetranortriterpenoid of natural origin. J. Gen. Virol. 2004, 85:483-493.
4. Barquero A.A., Michelini F.M., Alché L.E. 1-Cinnamoyl-3,11-dihydroxymeliacarpin is a natural bioactive compound with antiviral and nuclear factor-kappaB modulating properties. Biochem. Biophys. Res. Commun. 2006, 344:955-962.
5. Biswas P.S., Rouse B.T. Early events in HSV keratitis - setting the stage for a blinding disease. Microbes Infect. 2005, 7:799-810.
6. Biswas P.S., Banerjee K., Kinchington P.R., Rouse B.T. Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection. Exp. Eye Res. 2006, 82:46-54.
7. Bueno C.A., Barquero A.A., Di Cónsoli H., Maier M.S., Alché L.E. A natural tetranortriterpenoid with immunomodulating properties as a potential anti-HSV agent. Virus Res. 2009, 141:47-54.
8. Bueno C.A., Alché L.E., Barquero A.A. 1-Cinnamoyl-3,11-dihydroxymeliacarpin delays glycoprotein transport restraining virus multiplication without cytotoxicity. Biochem. Biophys. Res. Commun. 2010, 393:32-37.
9. Carrasco M.A. Subconjunctival bevacizumab for corneal neovascularization in herpetic stromal keratitis. Cornea 2008, 27:743-745.
10. Cook K.M., Figg W.D. Angiogenesis inhibitors: current strategies and future prospects. CA Cancer J. Clin. 2010, 60:222-243.
11. Davel L.E., Rimmaudo L., Español A., De La Torre E., Jasnis M.A., Ribeiro M.L., Gotoh T., de Lustig E.S., Sales M.E. Different mechanisms lead to the angiogenic process induced by three adenocarcinoma cell lines. Angiogenesis 2004, 7:45-51.
12. De Luisi A., Mangialardi G., Ria R., Acuto G., Ribatti D., Vacca A. Anti-angiogenic activity of carebastine: a plausible mechanism affecting airway remodelling. Eur. Respir. J. 2009, 34:958-966.
13. Denizot F., Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods 1986, 89:271-277.
14. Duan R., de Vries R.D., Osterhaus A.D., Remeijer L., Verjans G.M. Acyclovir-resistant corneal HSV-1 isolates from patients with herpetic keratitis. J. Infect. Dis. 2008, 198:659-663.
15. Ebrahem Q., Minamoto A., Hoppe G., Anand-Apte B., Sears J. Triamcinolone acetonide inhibits IL-6 and VEGF-induced angiogenesis downstream of the IL-6 and VEGF receptors. Invest. Ophthalmol. Vis. Sci. 2006, 47:4935-4941.
16. Fujita S., Saika S., Kao W., Fujita K., Miyamoto T., Ikeda K., Nakajima Y., Ohnishi Y. Endogenous TNFalpha suppression of neovascularization in corneal stroma in mice. Invest. Ophthalmol. Vis. Sci. 2007, 48:3051-3055.
17. Hashizume M., Hayakawa N., Suzuki M., Mihara M. IL-6/sIL-6R trans-signalling, but not TNF-alpha induced angiogenesis in a HUVEC and synovial cell co-culture system. Rheumatol. Int. 2009, 29:1449-1454.
18. He M.F., Liu L., Ge W., Shaw P.C., Jiang R., Wu L.W., But P.P. Antiangiogenic activity of Tripterygium wilfordii and its terpenoids. J. Ethnopharmacol. 2009, 121:61-68.
19. Knickelbein J.E., Hendricks R.L., Charukamnoetkanok P. Management of herpes simplex virus stromal keratitis: an evidence-based review. Surv. Ophthalmol. 2009, 54:226-234.
20. Lin C.M., Chang H., Chen Y.H., Li S.Y., Wu I.H., Chiu J.H. Protective role of wogonin against lipopolysaccharide-induced angiogenesis via VEGFR-2, not VEGFR-1. Int. Immunopharmacol. 2006, 6:1690-1698.
21. Pifarré M.P., Berra A., Coto C.E., Alché L.E. Therapeutic action of meliacine, a plant-derived antiviral, on HSV-induced ocular disease in mice. Exp. Eye Res. 2002, 75:327-334.
22. Radtke S., Wüller S., Yang X., Lippok B.E., Mütze B., Mais C., de Leur H.S., Bode J.G., Gaestel M., Heinrich P.C., Behrmann I., Schaper F., Hermanns H.M. Cross-regulation of cytokine signaling: pro-inflammatory cytokines restrict IL-6 signaling through receptor internalization and degradation. J. Cell Sci. 2010, 123:947-959.
23. Urtreger A., Ladeda V., Puricelli L., Rivelli A., Vidal M., Delustig E., Joffe E. Modulation of fibronectin expression and proteolytic activity associated with the invasive and metastatic phenotype in two new murine mammary tumor cell lines. Int. J. Oncol. 1997, 11:489-496.
24. Yeung S.N., Lichtinger A., Kim P., Amiran M.D., Slomovic A.R. Combined use of subconjunctival and intracorneal bevacizumab injection for corneal neovascularization. Cornea 2011, 30:1110-1114.
25. Zheng M., Schwarz M.A., Lee S., Kumaraguru U., Rouse B.T. Control of stromal keratitis by inhibition of neovascularization. Am. J. Pathol. 2001, 159:1021-1029.
26. Zheng M.E., Deshpande S., Lee S., Ferrara N., Rouse B.T. Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis. J. Virol. 2001, 75:9828-9835.